Lam Research (LRCX) Is Considered a Good Investment by Brokers: Is That True?

25.10.24 15:30 Uhr

Werte in diesem Artikel
Aktien

715,40 EUR -166,80 EUR -18,91%

Indizes

20.887,9 PKT 83,0 PKT 0,40%

19.139,8 PKT 85,0 PKT 0,45%

1.854,4 PKT -8,4 PKT -0,45%

5.997,9 PKT 10,5 PKT 0,18%

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Let's take a look at what these Wall Street heavyweights have to say about Lam Research (LRCX) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Lam Research currently has an average brokerage recommendation (ABR) of 1.74, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 27 brokerage firms. An ABR of 1.74 approximates between Strong Buy and Buy.Of the 27 recommendations that derive the current ABR, 16 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 59.3% and 7.4% of all recommendations.Brokerage Recommendation Trends for LRCXCheck price target & stock forecast for Lam Research here>>>While the ABR calls for buying Lam Research, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.Zacks Rank Should Not Be Confused With ABRAlthough both Zacks Rank and ABR are displayed in a range of 1-5, they are different measures altogether.The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.Should You Invest in LRCX?In terms of earnings estimate revisions for Lam Research, the Zacks Consensus Estimate for the current year has declined 8.1% over the past month to $3.24.Analysts' growing pessimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates lower, could be a legitimate reason for the stock to plunge in the near term.The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #4 (Sell) for Lam Research. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Therefore, it could be wise to take the Buy-equivalent ABR for Lam Research with a grain of salt.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.7% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lam Research Corporation (LRCX): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Lam Research

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Lam Research

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Lam Research Corp.

Analysen zu Lam Research Corp.

DatumRatingAnalyst
25.04.2019Lam Research OutperformCowen and Company, LLC
22.04.2019Lam Research BuyB. Riley FBR
24.01.2019Lam Research OutperformCowen and Company, LLC
21.12.2018Lam Research BuyNeedham & Company, LLC
29.10.2018Lam Research NeutralB. Riley FBR
DatumRatingAnalyst
25.04.2019Lam Research OutperformCowen and Company, LLC
22.04.2019Lam Research BuyB. Riley FBR
24.01.2019Lam Research OutperformCowen and Company, LLC
21.12.2018Lam Research BuyNeedham & Company, LLC
17.10.2018Lam Research OutperformCowen and Company, LLC
DatumRatingAnalyst
29.10.2018Lam Research NeutralB. Riley FBR
01.10.2018Lam Research HoldDeutsche Bank AG
01.10.2018Lam Research NeutralMizuho
12.10.2016Lam Research Sector WeightPacific Crest Securities Inc.
21.04.2015Lam Research Sector PerformRBC Capital Markets
DatumRatingAnalyst
22.10.2015Lam Research UnderperformRBC Capital Markets
05.10.2015Lam Research UnderperformRBC Capital Markets
11.11.2010Lam Research sellCitigroup Corp.
29.07.2010Lam Research sellCitigroup Corp.
19.03.2009Lam Research underperformCredit Suisse Group

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Lam Research Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"